BETH ISRAEL DEACONESS MEDICAL CENTER;THE GENERAL HOSPITAL CORPORATION;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
MARK A. EXLEY,SAMUEL B. WILSON,STEVEN P. BALK
申请号:
PT01946572
公开号:
PT1297017E
申请日:
2001.06.19
申请国别(地区):
PT
年份:
2012
代理人:
摘要:
The invention provides compounds and methods for the ex vivo or in vivo<; expansion of NK T cells, CD1d-reactive T cells, and J alpha Q<;+>; cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.